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Although a number of imaging modalities are available to
non-invasively evaluate patients with suspected or known
coronary artery disease (CAD), myocardial perfusion scintig-
raphy (MPS) with single photon emission computed tomog-
raphy (SPECT) has been the workhorse for this purpose for
over decades [1]. Notwithstanding its high sensitivity to detect
ischaemia (85–90 %), a caveat of a normal perfusion
scintigram is the fact that it can also be compatible with
balanced ischaemia due to multi-vessel or left main disease
[2]. (Fig. 1). A normal scan must therefore be interpreted with
care, and a further refinement in risk stratification is warranted
even in the presence of a seemingly reassuring result. In this
issue of the Netherlands Heart Journal, Bom et al. report on
the prognostic value of a normal MPS during a 2-year follow-
up period in 762 patients without a prior history of CAD [3].
The event rate was low (4.2 %) and predominantly driven by
revascularisation. Cardiac death and non-fatal myocardial in-
farction occurred in only nine patients (1.2 %). These results
are consistent with pooled analysis from large databases com-
prising close to 40,000 patients, which yield an annualised
event rate of 0.6 % following a normal perfusion SPECT scan
[4].Multivariate analysis by Bom and colleagues revealed that
male gender, a positive stress ECG, and a reduced left ven-
tricular (LV) ejection fraction (<45 %) had a negative impact
on prognosis. Some other well-documented prognostic risk
factors such as age, type of stressor (adenosine vs. exercise),
renal failure, and diabetes failed to reach statistical signifi-
cance, which is probably attributable to the relatively limited
sample size of the current study. These data highlight that a
normal test result must be interpreted in light of the clinical
risk profile of the patient, i.e. the pre-test likelihood of disease.
According to Bayes’ theorem, a negative test should alert us
when pre-test probability is high as it does not rule out disease
as it does when pre-test probability is low.
Besides clinical risk factors, alternative imaging parameters
may also aid in further risk stratification of a normal MPS.
Transient ischaemic dilation (TID) has been linked to exten-
sive CAD due to post-stress LV dysfunction, as a result of
stunning and/or diffuse subendocardial hypoperfusion, which
mimics LV enlargement by reduced subendocardial tracer
uptake during stress. Abidov et al. explored the prognostic
value of TID in patients with a completely normal MPS and
identified TID (with an optimal stress-to-rest ratio of 1.21) as
an independent prognostic factor with a threefold increase in
event rate [5]. In recent years, nuclear imaging has been fused
with computed tomography (CT) to facilitate CT-based atten-
uation correction, but additionally allows to acquire calcium
scoring (CAC) and CT coronary angiography (CCTA) within
a single scanning session [6]. Combining CAC with myocar-
dial perfusion imaging adds incremental prognostic value in
patients with and without myocardial ischaemia, although
ischaemia appears to be a more potent predictor of future
cardiac events than coronary calcification [7]. Improved risk
stratification, by adding anatomical information of CCTA to
functional data obtained withMPS, has also been documented
by Van Werkhoven et al. [8] Annualised hard event rate of a
normal MPS significantly increased when CCTA displayed a
coronary lesion of more than 50 % (0.6 vs. 3.8 %).
Another powerful prognostic indicator is quantitative per-
fusion imaging. As already alluded to in Fig. 1, SPECT is a
qualitative imaging technique whereby perfusion defects are
identified based on the relative distribution of the tracer.
Unfortunately, conditions that are accompanied by lack of
normal myocardium to act as a reference limit such a qualita-
tive approach and may yield false-negative results or under-
estimate the extent of disease (e.g. in case of multivessel
disease and/or microvascular dysfunction). Cardiac positron
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emission tomography (PET), however, is becoming increas-
ingly available and offers the possibility to quantify myocar-
dial blood flow in absolute terms (i.e. ml min−1 g−1) and
calculate coronary flow reserve (CFR) [9]. A number of
quantitative cardiac perfusion PET studies have unambigu-
ously demonstrated that a blunted CFR (generally defined
<2), in the presence of apparently normal relative myocardial
perfusion imaging, is accompanied by an unfavourable prog-
nosis as compared with preserved flow reserve [6]. Moreover,
this effect is the strongest predictor for adverse cardiac events
in symptomatic patients with normal relative myocardial per-
fusion imaging, and trumps clinical risk scores as well as
calcium scoring [10].
The study by Bom et al. reminds us that a normal MPS is
not necessarily accompanied by a benign clinical course and
may not always unveil potential serious coronary pathology.
Fortunately, advances in imaging techniques enhance the di-
agnostic and prognostic evaluation of this category of patients.
Nonetheless, a pivotal issue remains. These novel insights on
the prognostic value of patient characteristics and imaging
parameters have yet to be translated into improved patient
outcome. At present, it is unclear whether a myocardial per-
fusion imaging guided treatment strategy in patients with
overt ischaemia can improve outcome. This will prove to be
even more difficult to ascertain in patients with a normal MPS
and, on average, low event rate.
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